The Personalization of Clopidogrel Antiplatelet Therapy in Coronary Artery Disease Patients using Pharmacometabonomics, Pharmacogenetics and Platelets Function Testing
Clopidogrel is a substantial antiplatelet drug. Some patients on clopidogrel treatment suffer from high on treatment suffer from high on treatment platelets reactivity (HTPR) which may lead to poor outcome.
| मुख्य लेखक: | |
|---|---|
| स्वरूप: | थीसिस |
| भाषा: | अंग्रेज़ी |
| प्रकाशित: |
2016
|
| विषय: | |
| ऑनलाइन पहुंच: | http://eprints.usm.my/36317/ |
| Abstract | Abstract here |